KCNC1‐Related Progressive Myoclonus Epilepsy: A Case Report
Open Access
- 4 August 2025
- journal article
- Published by Wiley in Clinical Case Reports
- Vol. 13 (8)
Abstract
KCNC1‐related progressive myoclonus epilepsy (EPM7) is a rare disorder causing seizures, myoclonus, and ataxia. The first reported Iranian case highlights the role of genetic testing in diagnosis and potential future treatments, including gene therapy and novel pharmacological approaches.Keywords
This publication has 14 references indexed in Scilit:
- KCND3-Related Neurological Disorders: From Old to Emerging Clinical PhenotypesInternational Journal of Molecular Sciences, 2020
- The best evidence for progressive myoclonic epilepsy: A pathway to precision therapySeizure: European Journal of Epilepsy, 2019
- Pharmacological rescue of mutated Kv3.1 ion-channel linked to progressive myoclonus epilepsiesEuropean Journal of Pharmacology, 2018
- Familial cases of progressive myoclonic epilepsy caused by maternal somatic mosaicism of a recurrent KCNC1 p.Arg320His mutationBrain and Development, 2018
- Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K+ channel propertiesAnnals of Neurology, 2017
- Loss of Function of KCNC1 is associated with intellectual disability without seizuresEuropean Journal of Human Genetics, 2017
- Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutationsEpileptic Disorders, 2016
- Progressive Myoclonus Epilepsy of Unverricht‐Lundborg TypeEpilepsia, 1999
- GeneReviews®1993
- Progressive myoclonus epilepsy: Dentato-rubro-pallido-luysian atrophy (DRPLA) in childhoodBrain and Development, 1991